INIT — Initiator Pharma A/S Balance Sheet
0.000.00%
- SEK368.40m
- SEK348.73m
Annual balance sheet for Initiator Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | DAS | DAS | DAS | — | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 13.5 | 34.3 | 39.1 | 24.3 | 13.4 |
Net Total Receivables | 2.03 | 4.13 | 7.21 | 5.43 | 1.9 |
Prepaid Expenses | |||||
Total Current Assets | 15.6 | 53.7 | 48.3 | 29.8 | 15.3 |
Net Property, Plant And Equipment | 0 | — | 0.017 | — | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 15.6 | 53.7 | 48.3 | 29.8 | 15.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.19 | 5.42 | 1.75 | 3.19 | 0.51 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.19 | 18.7 | 14.3 | 18.6 | 0.51 |
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 14.4 | 35 | 34 | 11.2 | 14.8 |
Total Liabilities & Shareholders' Equity | 15.6 | 53.7 | 48.3 | 29.8 | 15.3 |
Total Common Shares Outstanding |